Statin Therapy

In patients aged 75 years of age or older taking statins for primary CVD prevention, discontinuing statin therapy was associated with a 33% increased risk for hospital admission for a CV event, researchers reported.

The American Heart Association and the American College of Cardiology, in collaboration with multiple other societies, recently published two highly significant documents in the field of preventive cardiology.

A relative paucity of evidence guiding the use of statin therapy in the primary prevention of atherosclerotic CVD events has led to disparate treatment strategies recommended by various medical associations.

Statins have pleiotropic effects, ie the ability to reduce heart disease risk and CV death via an unknown mechanism, certainly beyond the LDL cholesterol lowering that they can achieve.

Right now, 40 million Americans take statins to lower cholesterol in an attempt to prevent complications of atherosclerosis such as heart disease and stroke.